Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208507 · ClinicalTrials.gov registry record · NA
28 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study
A NA study, sponsored by DePuy Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 264
- Enrollment target
NCT00208507: Completed NA study, sponsored by DePuy Orthopaedics.
NCT00208507 is a NA study that has completed, run by DePuy Orthopaedics. The registered enrollment target is 264 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00208507, a NA study, has completed, sponsored by DePuy Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 264 participants
- Enrollment target
Study Summary
The study is designed to evaluate artificial hips with a 28 mm ceramic head and a ceramic liner to determine whether they perform as well as artificial hips with a 28 mm ceramic head and a polyethylene liner.
Primary Outcome
The Harris Hip scoring system assigns a numeric value to responses from patients and assessments made by a surgeon. Scores ranges from a minimum of zero to a maximum score of 100. A score of 91-100 is excellent, 81-90 is good, 71-80 is fair, 70 or below is poor. The patient records the following: pain level, need for assistance when walking, presence of a limp, distance able to walk, ability to put on shoes and socks, climb stairs, use public transportation and the length of time one is able to
Interventions
- DEVICE 28 mm ceramic head on ceramic acetabular liner.
- DEVICE 28 mm ceramic head on polyethylene liner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2003-04-01 |
| Est. Completion | 2012-01-05 |
| Phase | NA |
What the finished NCT00208507 record still lists
NCT00208507 is an interventional study that assigns participants to a tested intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which 28 mm ceramic head on ceramic acetabular liner. is the first listed.
NCT00208507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00208507 about?
NCT00208507 is a clinical study titled "28 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study". The study is designed to evaluate artificial hips with a 28 mm ceramic head and a ceramic liner to determine whether they perform as well as artificial hips with a 28 mm ceramic head and a polyethylene liner.
What is the current status of trial NCT00208507?
This trial is currently completed. It is a NA study. The enrollment target is 264 participants. The study started on 2003-04-01. Estimated completion is 2012-01-05.
What interventions are being tested in trial NCT00208507?
The interventions under investigation include: 28 mm ceramic head on ceramic acetabular liner. (DEVICE), 28 mm ceramic head on polyethylene liner (DEVICE).
Who is sponsoring clinical trial NCT00208507?
This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00208507's enrollment target sits among peer trials
264 395th of 2000 higher than 1,605 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
- NCT04295863 · 264 participants · Phase 1
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
- NCT05220202 · 264 participants · NA
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
- NCT05473013 · 264 participants · NA
Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI